Cibus Inc's fundamentals are relatively stable, and its growth potential is good.Its valuation is considered fairly valued, ranking 140/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.40.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current strong trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cibus Inc's Score
Industry at a Glance
Industry Ranking
140 / 208
Overall Ranking
353 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Buy
Current Rating
14.400
Target Price
+805.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cibus Inc Highlights
StrengthsRisks
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 2614.65% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.26M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.26M.
Fairly Valued
The company’s latest PE is -0.63, at a medium 3-year percentile range.
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Ticker SymbolCBUS
CompanyCibus Inc
CEOBeetham (Peter Ronald)
Websitehttps://www.cibus.com/
FAQs
What is the current price of Cibus Inc (CBUS)?
The current price of Cibus Inc (CBUS) is 1.710.
What is the symbol of Cibus Inc?
The ticker symbol of Cibus Inc is CBUS.
What is the 52-week high of Cibus Inc?
The 52-week high of Cibus Inc is 3.500.
What is the 52-week low of Cibus Inc?
The 52-week low of Cibus Inc is 1.090.
What is the market capitalization of Cibus Inc?
The market capitalization of Cibus Inc is 89.89M.
What is the net income of Cibus Inc?
The net income of Cibus Inc is -251.39M.
Is Cibus Inc (CBUS) currently rated as Buy, Hold, or Sell?
According to analysts, Cibus Inc (CBUS) has an overall rating of Buy, with a price target of 14.400.
What is the Earnings Per Share (EPS TTM) of Cibus Inc (CBUS)?
The Earnings Per Share (EPS TTM) of Cibus Inc (CBUS) is -2.713.